iBGStar™ Blood Glucose Monitoring System

iBGStar blood glucometer attachment for the iPhone, developed by AgaMatrix and commercialized by Sanofi, has received FDA approval.  The iBGStar uses the iPhone as a beautiful visualization tool to keep track of glucose readings, food and insulin intake, and exercise.

The device can be used independently of the iPhone to take readings and data will be transferred to the iPhone once the two are connected again.

The device has gone on sale in some EU countries earlier this year and American launch is expected shortly.

The iBGStar™ Diabetes Manager App has a range of features that allow users multiple ways to analyze their glucose patterns over time. Patients can record and track readings, carbohydrate intake and insulin doses if taking insulin. Scorecards show individual test results and are color coded so that high and low blood glucose results can be more easily identified. The ‘Share’ function enables users to select specific data to send as an e-mail to their healthcare professional. The application can be downloaded for free from the App Store.iBGStar Blood Glucose Meter

The iBGStar™ uses patented Dynamic Electrochemistry®1 technology that provides accurate results by helping to detect and correct for errors caused by differences in hematocrit 2 levels, manufacturing variations and certain environmental conditions

The compact iBGStar™ glucose meter, when plugged directly into the iPhone® or iPod® touch, quickly displays results immediately after testing on the full-color touch screen via the iBGStar™ Diabetes Manager App. iBGStar™ also can be used alone to measure blood glucose levels and results can be synchronized to an iPhone® or iPod® touch at a later time.

The iBGStar™ Diabetes Manager App has a range of features that allow users multiple ways to analyze their glucose patterns over time. Patients can record and track readings, carbohydrate intake and insulin doses if taking insulin. Scorecards show individual test results and are color coded so that high and low blood glucose results can be more easily identified. The ‘Share’ function enables users to select specific data to send as an e-mail to their healthcare professional. The application can be downloaded for free from the App Store.

The iBGStar™ uses patented Dynamic Electrochemistry®1 technology that provides accurate results by helping to detect and correct for errors caused by differences in hematocrit 2 levels, manufacturing variations and certain environmental conditions.

Further information is available at www.ibgstar.us.

In March 2010, Sanofi and AgaMatrix signed an agreement for the development, supply and commercialization of Blood Glucose Monitoring (BGM) solutions. iBGStar™ is among the first products of this agreement.

The iBGStar™ received the red dot design award 2011 for outstanding product design in the life science and medicine category. The red dot design award is one of the most renowned international design competitions (www.red-dot.de/presse), with almost 14,000 entries from 68 countries in the year 2010 alone. Winners are considered to be the best design in the industry worldwide.

Apple®, iPhone® and iPod touch® are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.

Sanofi strives to help people manage the complex challenges of diabetes by delivering innovative, integrated and personalized solutions.  Driven by valuable insight that comes from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices.  Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes.  Investigational compounds in the pipeline include an injectable GLP-1 agonist being studied as a single agent, in combination with basal insulins, and/or in combination with oral antidiabetic agents.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US, also referred to as Sanofi-aventis U.S. LLC.

Source:http://medgadget.com/2011/12/ibgstar-blood-glucose-meter-for-iphone-now-approved-in-u-s.html,http://sanofi.mediaroom.com/index.php?s=64&item=57

Related Posts Plugin for WordPress, Blogger...
Be Sociable, Share!

About the Author

has written 157 posts on this blog.

Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes